New Zealand's a2 Milk NZX:ATM on Tuesday said that certain factors contributing to the availability of its key Chinese-label infant milk formula (IMF) product are substantially resolved, but have contributed to an around 14% decline in annual sales for the product.
However, the dairy producer added it now expects net profit after tax for fiscal 2026 to be slightly higher than last year's NZ$202.9 million ($115.63 million), compared with its earlier outlook of similar or lower earnings.
($1 = 1.7547 New Zealand dollars)